You are here

Home » University of California, Davis Medical Center

University of California, Davis Medical Center

2315 Stockton Blvd
Sacramento, CA 95817
United States

Targeting Childhood Brain Cancer in a Dish to Catalyze New Therapies

Glioma

This study examines H3.3, an attractive new target in the search for therapies specifically designed for pediatric gliomas.

Histone H3.3 Targeted Therapy for Pediatric High-grade Gliomas

Brain Tumors, Glioma, Medulloblastoma, Neuroblastoma

Background

High-grade pediatric gliomas are catastrophic cancers. Greater than 90% of children with these tumors die within two years of diagnosis even with today's best treatments, which are based on adult therapies and have devastating side effects. There is an urgent need for new, more effective therapies that are specifically designed for children because pediatric gliomas are different from adult.

Featured Hero

Chris Ramirez

Chris loves baseball – he has a history of playing for his high school team and is a longtime fan of the San Francisco Giants. However, when he was in high school, Chris began having strange symptoms. Today, Chris is a three-time survivor of glioblastoma.
Read more »